Client Profile

Biomodels’ clients reflect the full range of the pharmaceutical and biotechnology industry. In addition to efficacy studies of their own compounds, “big pharma” has found Biomodels to be an efficient partner to identify and evaluate potential halo applications for existing drugs, and to evaluate the potential usefulness and value of potential acquisitions or licenses. Biomodels has provided mid- and small-size companies with an extremely cost-effective way to identify and triage lead candidate compounds for development and to optimize formulation, dosing, and scheduling. For many companies, using Biomodels as their preclinical study resource has obviated the expense of brick and mortar laboratory facilities. Results of Biomodels studies have added value to compounds as companies seek partners, funding or licenses. And companies of all sizes have benefited from Biomodels collaborations to define mechanisms of action of compounds relative to a specific clinical condition.